goat anti cd36 antibody (R&D Systems)
Structured Review
Goat Anti Cd36 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 92/100, based on 16 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/goat+anti-cd36/Human+CD36%2FSR-B3+Antibody/pm40683443-76-24-29
Average 92 stars, based on 16 article reviews
Images
Related Articles
Incubation:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Expressing:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Western Blot:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Real-time Polymerase Chain Reaction:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Immunostaining:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Staining:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with In Vivo:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Binding Assay:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Injection:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Membrane:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Translocation Assay:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Inhibition:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Plasmid Preparation:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Activation Assay:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Co-Immunoprecipitation Assay:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Negative Control:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Muscles:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with SDS Page:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Proximity Ligation Assay:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Amplification:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Transfection:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with Mutagenesis:Article Title: Nalmefene, an opioid receptor modulator, aggravates atherosclerotic plaque formation in apolipoprotein E knockout mice by enhancing oxidized low-density lipoprotein uptake in macrophages Article Snippet: The blot was incubated with Article Title: Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling Article Snippet: After incubation for 16 h with |
